Korean J Gastroenterol.  2022 Jan;79(1):49-51. 10.4166/kjg.2022.004.

Are Proton Pump Inhibitors a Risk Factor for Gastric Cancer?

• Boo SJ

• KMID: 2525524
• DOI: http://doi.org/10.4166/kjg.2022.004

Abstract

Proton Pump Inhibitors and Risk of Gastric Cancer: Population-based Cohort Study

Reference

1. Vaezi MF, Yang YX, Howden CW. 2017; Complications of proton pump inhibitor therapy. Gastroenterology. 153:35–48. DOI: 10.1053/j.gastro.2017.04.047. PMID: 28528705.

2. Lundell L, Vieth M, Gibson F, Nagy P, Kahrilas PJ. 2015; Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology. Aliment Pharmacol Ther. 42:649–663. DOI: 10.1111/apt.13324. PMID: 26177572.

3. Joo MK, Park JJ, Chun HJ. 2019; Proton pump inhibitor: the dual role in gastric cancer. World J Gastroenterol. 25:2058–2070. DOI: 10.3748/wjg.v25.i17.2058. PMID: 31114133. PMCID: PMC6506576.

4. Abrahami D, McDonald EG, Schnitzer ME, Barkun AN, Suissa S, Azoulay L. 2022; Proton pump inhibitors and risk of gastric cancer: population-based cohort study. Gut. 71:16–24. DOI: 10.1136/gutjnl-2021-325097. PMID: 34226290.

5. Seo SI, Park CH, You SC, et al. 2021; Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea. Gut. 70:2066–2075. DOI: 10.1136/gutjnl-2020-323845. PMID: 33975868.

6. Zeng R, Sha W, Wang J, et al. Evaluation of proton pump inhibitors and risks of gastric cancer. Gut. 2021; Nov. 26. [Epub ahead of print]. DOI: 10.1136/gutjnl-2021-326291. PMID: 34836917.

7. Shin GY, Park JM, Hong J, Cho YK, Yim HW, Choi MG. 2021; Use of proton pump inhibitors vs histamine 2 receptor antagonists for the risk of gastric cancer: population-based cohort study. Am J Gastroenterol. 116:1211–1219. DOI: 10.14309/ajg.0000000000001167. PMID: 34074826.

8. Brusselaers N, Lagergren J, Engstrand L. 2019; Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer. Cancer Epidemiol. 62:101585. DOI: 10.1016/j.canep.2019.101585. PMID: 31445426.

9. Cheung KS, Chan EW, Wong AYS, Chen L, Wong ICK, Leung WK. 2018; Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study. Gut. 67:28–35. DOI: 10.1136/gutjnl-2017-314605. PMID: 29089382.

10. Liu P, McMenamin ÚC, Johnston BT, et al. 2020; Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies. Br J Cancer. 123:307–315. DOI: 10.1038/s41416-020-0860-4. PMID: 32367073. PMCID: PMC7374738.

11. Ng AK, Ng PY, Ip A, Cheung KS, Siu CW. 2021; Association between proton pump inhibitors after percutaneous coronary intervention and risk of gastric cancer. BMJ Open Gastroenterol. 8:e000719. DOI: 10.1136/bmjgast-2021-000719. PMID: 34380699. PMCID: PMC8359470.

12. Niikura R, Hayakawa Y, Hirata Y, Yamada A, Fujishiro M, Koike K. 2018; Long-term proton pump inhibitor use is a risk factor of gastric cancer after treatment for Helicobacter pylori: a retrospective cohort analysis. Gut. 67:1908–1910. DOI: 10.1136/gutjnl-2017-315710. PMID: 29273641.

13. Poulsen AH, Christensen S, McLaughlin JK, et al. 2009; Proton pump inhibitors and risk of gastric cancer: a population-based cohort study. Br J Cancer. 100:1503–1507. DOI: 10.1038/sj.bjc.6605024. PMID: 19352380. PMCID: PMC2694435.

14. Dacha S, Razvi M, Massaad J, Cai Q, Wehbi M. 2015; Hypergastrinemia. Gastroenterol Rep (Oxf). 3:201–208. DOI: 10.1093/gastro/gov004. PMID: 25698559. PMCID: PMC4527266.

15. Wroblewski LE, Peek RM Jr, Coburn LA. 2016; The role of the microbiome in gastrointestinal cancer. Gastroenterol Clin North Am. 45:543–556. DOI: 10.1016/j.gtc.2016.04.010. PMID: 27546848. PMCID: PMC4994977.

16. Li Z, Wu C, Li L, et al. 2017; Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: a meta-analysis. Saudi J Gastroenterol. 23:222–228. DOI: 10.4103/sjg.SJG_573_16. PMID: 28721975. PMCID: PMC5539675.

17. Jiang K, Jiang X, Wen Y, Liao L, Liu FB. 2019; Relationship between long-term use of proton pump inhibitors and risk of gastric cancer: a systematic analysis. J Gastroenterol Hepatol. 34:1898–1905. DOI: 10.1111/jgh.14759. PMID: 31206764.